In-stent restenosis after revascularization of myocardium with drug-eluting stents is accompanied by elevated level of blood plasma eosinophil cationic protein

Author： Gabbasov Zufar A.   Kozlov Sergei G.   Imaeva Asiya E.   Saburova Olga S.   Zykov Kirill A.   Masenko Valery P.   Smirnov Vladimir N.  

Publisher： NRC Research Press

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.89, Iss.6, 2011-06, pp. : 413-418

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug-eluting stents beat other therapies for in-stent restenosis

By  

Inpharma, Vol. 1, Iss. 1577, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Polymorphonuclear blood leukocytes and restenosis after intracoronary implantation of drug-eluting stents

By Gabbasov Zufar A.   Kozlov Sergey G.   Lyakishev Anatoly A.   Saburova Olga S.   Smirnov Vladimir A.   Smirnov Vladimir N.  

Canadian Journal of Physiology and Pharmacology, Vol. 87, Iss. 2, 2009-02 ,pp. : 130-136

NRC Research Press

Access to resources Recommend Favorite

Drug-eluting stents: In-stent occlusion: case report

By  

Reactions Weekly, Vol. 1, Iss. 1232, 2008-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Sirolimus: Multiple stent fractures, in-stent restenosis, and stent thrombosis leading to sudden death following implantation of drug-eluting stents in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1265, 2009-01 ,pp. : 29-30

Adis International

Access to resources Recommend Favorite

Drug-eluting stents more desirable for recurrent restenosis

By  

Inpharma, Vol. 1, Iss. 1474, 2005-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite